Pharmafile Logo

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding and will now be known as OPEN Health.

London, UK – April 25, 2023 – Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding and will now be known as OPEN Health. The CM Group brands included decile.ten, the PX Group, and Scientific Commercialization.

Since its inception in 2011, OPEN Health has expanded its expertise and global reach through mergers, acquisitions, and organic growth to be at the forefront of the healthcare industry. It has brought together global experts from consulting, HEOR, market access, medical communications, and creative omnichannel communications to provide unrivaled global healthcare specialist expertise with the purpose of improving patient outcomes and wellbeing.

“We are proud to offer our clients a wide and unique range of global capabilities and geographies across an integrated service model,” said Rob Barker, CEO of OPEN Health. “We are delighted to integrate The CM Group into our global team of over 1,300 experts who partner with 38 of the top 40 biopharmaceutical and medical device companies, serving clients from Medical Affairs, HEOR, market access, and commercial teams.”

President of the recently acquired agency, Cherie Myatt, added, “For over 20 years, The CM Group has provided exceptional service to clients, due in large part to our passionate and dedicated team. We will continue to deliver on our promise as we integrate and expand our offerings with an equally dynamic team of experts. The integration journey with OPEN Health has been an exciting and rewarding one, and we are pleased to be able to now offer a wider range of expertise to our clients.”

About OPEN Health

OPEN Health unites deep scientific knowledge with wide‑ranging specialist expertise to unlock possibilities that improve health outcomes and patient wellbeing.

We are a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, and creative omnichannel communications.

For more information, please visit www.openhealthgroup.com.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Jeff Anderson joins OPEN Health as European Lead for OPEN VIE and Pharmerit

OPEN Health, the family of expert practices working in partnership to drive positive change in healthcare communications and market access, has appointed Jeff Anderson as European Lead for the combined...

OPEN Health Webinar - Succeeding with Star Wars Medicine

Summary of their recently published white paper on gene therapy followed by a Q&A session on 12th June 2020. Book now!

Yurie Oates, Account Director, OPEN Health gives us some Top tips from 5 years of account management on #MedCommsDay

WHAT IS ACCOUNT MANAGEMENT?Account/project managers support the day-to-day running of their account: they are the glue in a team who make sure projects are completed on brief, on time and...

A day in the life of an Associate Publications Director

Eleanor Raynsford, Associate Publications Director, OPEN Health gives us an insight into a day in the life of her role.

Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19

Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time.

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa

Ben Speller shares his thoughts on the value of disease specific congresses

OPEN Health use PR to support clinical trial recruitment

International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2

OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds

Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers

OPEN Health attend day 2 of the ECRD2020 congress

Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.

OPEN Health continued support for My Name'5 Doddie

Charity fundraising for Motor Neuron Disease